Crinetics Pharmaceuticals, Inc. Made Headway

Mon, Sep 11, 2023 at 07:24 PM
Crinetics Pharmaceuticals, Inc. Made Headway

Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ) soared at $26.08, representing a gain of 63.3%. On Mon, Sep 11, 2023, CRNX:NASDAQ touched a New 2-Week High of $26.08. The stock got featured on our News Catalysts scanner on Mon, Sep 11, 2023 at 04:39 PM in the 'PUBLIC OFFERING' category. From Mon, Aug 28, 2023, the stock recorded 33.33% Up Days and 30.00% Green Days

About Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ)

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.